Company news
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A (SSE:600671) news
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A news releases on 6ix. Latest, Nov 14, 2024: Announcement on Resolution of the 9th Meeting…
View Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A →
Press releases — page 2
Announcement on Resolution of the 9th Meeting of the 12th Board of Directors
November 13, 2024
Announcement on the Renewal of the Drug Distribution License of Holding Subsidiary
October 31, 2024
Announcement on Abnormal Fluctuations in Stock Trading and Risk Alert
October 30, 2024
Report for Q3 2024
October 29, 2024
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2024
October 28, 2024
Announcement on Renewing Engagement of Accounting Firm
October 10, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
October 9, 2024
Announcement on Receiving the Notice of Approval for Re-Registration of Drug
September 20, 2024